CINGW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCDAW, BCTXW, CDIOW, CTCXW, and CELUW
Should you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.
180 Life Sciences (NASDAQ:ATNFW) and Cingulate (NASDAQ:CINGW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking.
180 Life Sciences and Cingulate both received 0 outperform votes by MarketBeat users.
In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.
Summary
180 Life Sciences and Cingulate tied by winning 0 of the 0 factors compared between the two stocks.
Get Cingulate News Delivered to You Automatically
Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CINGW vs. The Competition
Cingulate Competitors List
Related Companies and Tools
